TESTOSTERON Mepha sol inj 1000 mg/4ml flac
7680689890012
CH-68989
G03BA03
07.08.4.
Reimbursement limitations:
TESTOSTERONM
Hypogonadisme primaire et secondaire.
Le traitement nécessite une garantie de prise en charge des …
1 / 3
google
Details
- Product number
- 6898901
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- testosteroni undecanoas 1 g corresp. testosteronum 631.5 mg, benzylis benzoas 2 g, ricini oleum raffinatum, ad solutionem pro 4 ml.
Articles (1)
Testosteron-Mepha 1000 mg / 4 ml, Injektionslösung
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
1.0 G | Substance | WIZUS |
|
(N/A)
|
631.5 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
2.0 G | Substance | HBESI |
|
(N/A)
|
- | Substance | HIMDK |
Reimbursement information
Public price
CHF 77.20
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/04/2024
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 68989
- Drug name
- Testosteron-Mepha, Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- G03BA03
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 28/11/2023
- Authorization expiration date
- 27/11/2028
- IT number
- 07.08.4.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TESTOSTERON Mepha sol inj 1000 mg/4ml flac
- Description (DE)
- TESTOSTERON Mepha Inj Lös 1000 mg/4ml Durchstf
- Market launch
- 28/11/2023
- Narcotic (BTM)
- No